1. Home
  2. GORO vs ANL Comparison

GORO vs ANL Comparison

Compare GORO & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Resource Corporation

GORO

Gold Resource Corporation

HOLD

Current Price

$0.82

Market Cap

112.3M

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$1.28

Market Cap

52.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GORO
ANL
Founded
1998
2004
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Precious Metals
Sector
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
112.3M
52.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
GORO
ANL
Price
$0.82
$1.28
Analyst Decision
Strong Buy
Hold
Analyst Count
2
1
Target Price
$1.38
N/A
AVG Volume (30 Days)
1.2M
25.3K
Earning Date
11-04-2025
04-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$61,430,000.00
N/A
Revenue This Year
$8.76
N/A
Revenue Next Year
$85.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$0.88
52 Week High
$1.18
$2.99

Technical Indicators

Market Signals
Indicator
GORO
ANL
Relative Strength Index (RSI) 59.38 46.80
Support Level $0.72 $0.88
Resistance Level $0.83 $1.59
Average True Range (ATR) 0.05 0.18
MACD 0.01 -0.01
Stochastic Oscillator 83.89 57.83

Price Performance

Historical Comparison
GORO
ANL

About GORO Gold Resource Corporation

Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: